Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 32, 2016 - Issue 7
824
Views
29
CrossRef citations to date
0
Altmetric
Articles

Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters

, , , , , , & show all
Pages 787-800 | Received 03 Feb 2016, Accepted 20 May 2016, Published online: 28 Jun 2016

References

  • Banin E, Brady KM, Greenberg EP. 2006. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 72:2064–2069. doi:10.1128/AEM.72.3.2064-2069.2006
  • Batoni G, Maisetta G, Esin S. 2016. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta. 1858:1044–1060. doi:10.1016/j.bbamem.2015.10.013
  • Beloin C, Renard S, Ghigo JM, Lebeaux D. 2014. Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol. 18:61–68. doi:10.1016/j.coph.2014.09.005
  • Brackman G, Coenye T. 2015. Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des. 21:5–11. doi:10.2174/1381612820666140905114627
  • Brancatisano FL, Maisetta G, Di Luca M, Esin S, Bottai D, Bizzarri R, Campa M, Batoni G. 2014. Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. Biofouling. 30:435–446. doi:10.1080/08927014.2014.888062
  • Chaignon P, Sadovskaya I, Ragunah Ch, Ramasubbu N, Kaplan JB, Jabbouri S. 2007. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl Microbiol Biotechnol. 75:125–132. doi:10.1007/s00253-006-0790-y
  • Chauhan A, Lebeaux D, Ghigo JM, Beloin C. 2012. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother. 56:6310–6318. doi:10.1128/AAC.01606-12
  • Di Grazia A, Luca V, Segev-Zarko LA, Shai Y, Mangoni ML. 2014. Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus. Antimicrob Agents Chemother. 58:2520–2527. doi:10.1128/AAC.02801-13
  • Di Luca M, Maccari G, Maisetta G, Batoni G. 2015. BaAMPs: the database of biofilm-active antimicrobial peptides. Biofouling. 31:193–199. doi:10.1080/08927014.2015.1021340
  • Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB. 2007. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 51:2733–2740. doi:10.1128/AAC.01249-06
  • Fey PD, Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 5:917–933. doi:10.2217/fmb.10.56
  • Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S. 2006. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 58:816–821. doi:10.1093/jac/dkl318
  • Gomes F, Teixeira P, Oliveira R. 2014. Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies. Biofouling. 30:131–141. doi:10.1080/08927014.2013.848858
  • Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.011
  • Justo JA, Bookstaver PB. 2014. Antibiotic lock therapy: review of technique and logistical challenges. Infect Drug Resist. 7:343–363. doi:10.2147/IDR.S51388
  • Kaplan JB, LoVetri K, Cardona ST, Madhyastha S, Sadovskaya I, Jabbouri S, Izano EA. 2012. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J Antibiot (Tokyo). 65:73–77. doi:10.1038/ja.2011.113
  • Kite P, Eastwood K, Sugden S, Percival SL. 2004. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol. 42:3073–3076. doi:10.1128/JCM.42.7.3073-3076.2004
  • Kogan G, Sadovskaya I, Chaignon P, Chokr A, Jabbouri S. 2006. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett. 255:11–16. doi:10.1111/j.1574-6968.2005.00043.x
  • Lebeaux D, Leflon-Guibout V, Ghigo JM, Beloin C. 2015. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J Antimicrob Chemother. 70:1704–1712. doi:10.1093/jac/dkv044
  • Maisetta G, Mangoni ML, Esin S, Pichierri G, Capria AL, Brancatisano FL, Di Luca M, Barnini S, Barra D, Campa M, et al. 2009. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1–18) in combination with conventional antibiotics against Stenotrophomonas maltophilia. Peptides. 30:1622–1626. doi:10.1016/j.peptides.2009.06.004
  • Mangoni ML. 2006. Temporins, anti-infective peptides with expanding properties. Cell Mol Life Sci. 63:1060–1069. doi:10.1007/s00018-005-5536-y
  • Mangoni ML, Grazia AD, Cappiello F, Casciaro B, Luca V. 2016. Naturally occurring peptides from Rana temporaria: antimicrobial properties and more. Curr Top Med Chem. 16:54–64.
  • Mangoni ML, Maisetta G, Di Luca M, Gaddi LM, Esin S, Florio W, Brancatisano FL, Barra D, Campa M, Batoni G. 2008. Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother. 52:85–91. doi:10.1128/AAC.00796-07
  • Mataraci E, Dosler S. 2012. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 56:6366–6371. doi:10.1128/AAC.01180-12
  • McIntyre CW, Hulme LJ, Taal M, Fluck RJ. 2004. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 66:801–805. doi:10.1111/j.1523-1755.2004.00806.x
  • Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 49:1–45. doi:10.1086/599376
  • Park SC, Park Y, Hahm KS. 2011. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci. 12:5971–5992. doi:10.3390/ijms12095971
  • Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM. 2005. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol. 26:515–519. doi:10.1086/502577
  • Piras AM, Maisetta G, Sandreschi S, Gazzarri M, Bartoli C, Grassi L, Esin S, Chiellini F, Batoni G. 2015. Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis. Front Microbiol. 6:372. doi:10.3389/fmicb.2015.00372
  • Raad I, Alrahwan A, Rolston K. 1998. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 26:1182–1187. doi:10.1086/520285
  • Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. 2003. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 47:3580–3585. doi:10.1128/AAC.47.11.3580-3585.2003
  • Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, Schininà ME, Simmaco M. 2001. Effects of temporins on molecular dynamics and membrane permeabilization in lipid vesicles. J Pept Res. 58:213–220. doi:10.1034/j.1399-3011.2001.00896.x
  • Segev-Zarko L, Saar-Dover R, Brumfeld V, Mangoni ML, Shai Y. 2015. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides. Biochem J. 468:259–270. doi:10.1042/BJ20141251
  • Shanks RM, Sargent JL, Martinez RM, Graber ML, O’Toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant. 21:2247–2255. doi:10.1093/ndt/gfl170
  • Sousa C, Henriques M, Oliveira R. 2011. Mini-review: Antimicrobial central venous catheters–recent advances and strategies. Biofouling. 27:609–620. doi:10.1080/08927014.2011.593261
  • Spiliopoulou AI, Krevvata MI, Kolonitsiou F, Harris LG, Wilkinson TS, Davies AP, Dimitracopoulos GO, Karamanos NK, Mack D, Anastassiou ED. 2012. An extracellular Staphylococcus epidermidis polysaccharide: relation to polysaccharide intercellular adhesin and its implication in phagocytosis. BMC Microbiol. 12:76. doi:10.1186/1471-2180-12-76
  • Strempel N, Strehmel J, Overhage J. 2015. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections. Curr Pharm Des. 21:67–84. doi:10.2174/1381612820666140905124312
  • Wu X, Wang Y, Tao L. 2011. Sulfhydryl compounds reduce Staphylococcus aureus biofilm formation by inhibiting PIA biosynthesis. FEMS Microbiol Lett. 316:44–50. doi:10.1111/j.1574-6968.2010.02190.x
  • Yousif A, Jamal MA, Raad I. 2015. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol. 830:157–179. doi:10.1007/978-3-319-11038-7_10

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.